RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors. (Record no. 21296639)

MARC details
000 -LEADER
fixed length control field 02451 a2200673 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516063340.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201205s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1527-7755
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1200/JCO.2011.36.7680
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Oberholzer, Patrick A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20120531
245 00 - TITLE STATEMENT
Title RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Date of publication, distribution, etc. Jan 2012
300 ## - PHYSICAL DESCRIPTION
Extent 316-21 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzenesulfonates
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Squamous Cell
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gene Expression Regulation, Neoplastic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genotype
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indoles
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mass Spectrometry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mitogen-Activated Protein Kinase Kinases
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Niacinamide
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phenylurea Compounds
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proto-Oncogene Proteins B-raf
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Skin Neoplasms
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sorafenib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonamides
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vemurafenib
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kee, Damien
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dziunycz, Piotr
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sucker, Antje
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kamsukom, Nyam
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jones, Robert
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Roden, Christine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chalk, Clinton J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ardlie, Kristin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Palescandolo, Emanuele
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Piris, Adriano
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name MacConaill, Laura E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Robert, Caroline
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hofbauer, Günther F L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McArthur, Grant A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schadendorf, Dirk
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garraway, Levi A
773 0# - HOST ITEM ENTRY
Title Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Related parts vol. 30
-- no. 3
-- p. 316-21
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1200/JCO.2011.36.7680">https://doi.org/10.1200/JCO.2011.36.7680</a>
Public note Available from publisher's website

No items available.